🔎 Trials Near Me

Home › Crohn's Disease › New Jersey

Crohn's Disease clinical trials in New Jersey

8 studies for Crohn's Disease are looking for participants at sites in New Jersey.

Cities in New Jersey

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • HMH Justice Marie Garibaldi Medical Plaza ( Site 5072), Hackensack
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Nov 10, 2026 · NCT06430801

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Goryeb Children's Hospital, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Nov 3, 2026 · NCT05923073

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Sanmora Bespoke Clinical Research Solutions LLC-Site Number: 8400123, East Orange
  • Allied Health Clinical Research Organization, LLC - Freehold-Site Number: 8400014, Freehold
  • Atlantic Health System, Morristown Medical Center-Site Number: 8400137, Morristown
  • and 2 more
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 21, 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Goryeb Childrens Hospital /ID# 256452, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Oct 20, 2026 · NCT05995353

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Atlantic Health - Morristown Medical Center, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Oct 9, 2026 · NCT06405087

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Atlantic Children's Health--Pediatric Gastroenterology, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Oct 7, 2026 · NCT05509777

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Goryeb Children's Hospital, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated May 5, 2026 · NCT04779320

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.